Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Ocugen, Inc (OCGN)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Ocugen's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.250 +0.010    +0.81%
15:13:20 - Real-time Cboe. Currency in USD ( Disclaimer )
  • Volume: 1,568,988
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.180 - 1.260
Type:  Equity
Market:  United States
Ocugen 1.250 +0.010 +0.81%

Ocugen Company Profile

 
Read the Ocugen, Inc company profile to learn more about the business and the management team. View Ocugen, Inc facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

65

Equity Type

ORD

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients’ health. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.

Contact Information

Address 11 Great Valley Parkway
Malvern, 19355
United States
Phone 484 328 4701
Fax -

Top Executives

Name Age Since Title
Shankar Musunuri 60 2019 Co-Founder, CEO & Chairman
Carl D. Regillo - 2019 Member of Retina Scientific Advisory Board
Prabhavathi B. Fernandes 75 2020 Independent Director
Ramesh Kumar 68 2019 Independent Director
Bruce D. Forrest 61 2020 Vaccine Scientific Advisory Board Member
Uday B. Kompella 57 2019 Co-founder & Independent Director
Joseph W. Westphal - 2023 Member of Business Advisory Board
David S. Boyer - - Member of Retina Scientific Advisory Board
Satishchandran Chandrasekhar - 2020 Vaccine Scientific Advisory Board Member
Geeta Lalwani - - Member of Retina Scientific Advisory Board
Junge Zhang 57 2019 Independent Director
Mark Pennesi - 2019 Member of Retina Scientific Advisory Board
Marna Cupp Whittington 76 2022 Independent Director
Catherine J. Pachuk 67 2020 Vaccine Scientific Advisory Board Member
David Fajgenbaum - 2020 Vaccine Scientific Advisory Board Member
Robert J. Smith 63 2024 Member of Business Advisory Board
Connie R. Collingsworth 65 2023 Member of Business Advisory Board
Susan Weiss - 2020 Vaccine Scientific Advisory Board Member
Kirsten M. Castillo 50 2020 Independent Director
Patrick J. Toomey 62 2023 Member of Business Advisory Board
Dennis C. Carey 66 2023 Member of Business Advisory Board
Harvey Rubin - 2020 Vaccine Scientific Advisory Board Member
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

OCGN Price Commentary

Write your thoughts about Ocugen, Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Qarnain Balushi
Qarnain Balushi May 04, 2023 11:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I invested 100k in ocgn hope to hit jackpot if it hits 2 ,to 4 dollar around
Zulkarnain Khoso Faiz
Zulkarnain Khoso Faiz Apr 21, 2022 14:18
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy and hold ,end of the year 10 dollar
Sorin Murgu
Sorin Murgu Apr 11, 2022 18:44
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy will go up!!!
Zulkarnain Khoso Faiz
Zulkarnain Khoso Faiz Mar 23, 2022 22:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
insanely cheap stock ,buy time
Sorin Murgu
Sorin Murgu Jan 19, 2022 21:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don’t invest 👍👍👍
Sorin Murgu
Sorin Murgu Dec 21, 2021 11:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Soon will go up!!!
Denis Korotkovs
Denis Korotkovs Dec 21, 2021 11:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when?
Andy Mun Heng
Andy Mun Heng Dec 21, 2021 11:25
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this stock is suck. I have been followed since last year..very disappointed.
Zulkarnain Khoso Faiz
Zulkarnain Khoso Faiz Dec 15, 2021 20:45
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy buy Santa Santa rally
Sarfraz Nawaz
Sarfraz Nawaz Nov 25, 2021 5:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
time to go up
Zulkarnain Khoso Faiz
Zulkarnain Khoso Faiz Nov 09, 2021 15:50
Saved. See Saved Items.
This comment has already been saved in your Saved Items
lovely wat a pump. .??
Zulkarnain Khoso Faiz
Zulkarnain Khoso Faiz Nov 04, 2021 17:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
buy here now long see u at 20 soon till December
Ali Hamidijavid
Ali Hamidijavid Nov 04, 2021 17:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bro where is your source,
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email